INGN logo

Inogen Stock Price

Symbol: NasdaqGS:INGNMarket Cap: US$219.3mCategory: Healthcare

INGN Share Price Performance

US$8.11
-3.22 (-28.42%)
42.1% undervalued intrinsic discount
US$14.00
Fair Value
US$8.11
-3.22 (-28.42%)
42.1% undervalued intrinsic discount
US$14.00
Fair Value
Price US$8.11
AnalystHighTarget US$14.00
AnalystConsensusTarget US$11.00
AnalystLowTarget US$7.00

INGN Community Narratives

AnalystHighTarget·Updated
Fair Value US$14.00 42.1% undervalued intrinsic discount

Aging Global Population And At-Home Care Will Boost Market Demand

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·Updated
Fair Value US$11.00 26.3% undervalued intrinsic discount

Home And Outpatient Respiratory Care Will Expand Market Opportunities

0users have liked this narrative
3users have commented on this narrative
5users have followed this narrative
AnalystLowTarget·Updated
Fair Value US$7.00 15.9% overvalued intrinsic discount

Pricing Pressures And Rivals Will Erode Portable Oxygen Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent INGN News & Updates

There's No Escaping Inogen, Inc.'s (NASDAQ:INGN) Muted Revenues Despite A 29% Share Price Rise

Aug 31
There's No Escaping Inogen, Inc.'s (NASDAQ:INGN) Muted Revenues Despite A 29% Share Price Rise

Inogen: Still Breathing, But Margin Pressures Persist

Jun 16

Analysts Have Been Trimming Their Inogen, Inc. (NASDAQ:INGN) Price Target After Its Latest Report

May 10
Analysts Have Been Trimming Their Inogen, Inc. (NASDAQ:INGN) Price Target After Its Latest Report

Inogen, Inc. Key Details

US$343.5m

Revenue

US$188.1m

Cost of Revenue

US$155.3m

Gross Profit

US$181.4m

Other Expenses

-US$26.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.96
Gross Margin
45.23%
Net Profit Margin
-7.58%
Debt/Equity Ratio
0%

Inogen, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Undervalued with excellent balance sheet.

1 Risk
2 Rewards

About INGN

Founded
2001
Employees
766
CEO
Kevin R. Smith
WebsiteView website
www.inogen.com

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Market Insight

Why today’s lofty prices test investors, and how to stay invested without losing your edge.
Continue reading

U.S. Market Performance

  • 7 Days: 0.5%
  • 3 Months: 8.2%
  • 1 Year: 20.8%
  • Year to Date: 10.6%
Over the last 7 days, the market has remained flat, although notably the Communication Services sector gained 4.7% in that time. More promisingly, the market is up 21% over the past year. Earnings are forecast to grow by 15% annually. Market details ›